Request Deal Involvement
Bayer to acquire Asklepios Bio from TPG Capital, Columbus Venture and Vida Ventures for c. $4bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
JP Morgan
legal advisors
Ropes & Gray
legal advisors
Skadden Arps Slate Meagher & Flom
financial advisors
Credit Suisse
legal advisors
Baker McKenzie
or
Principals
target
ASKLEPIOS BIOPHARMACEUTICAL INC
bidder
BAYER AG
vendor
VIDA VENTURES
vendor
TPG CAPITAL LP
vendor
COLUMBUS VENTURE
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite